Cannabinoid modulation of rat pup ultrasonic vocalizations

Area of Science:

• Neuroscience
• Behavioral Pharmacology
• Developmental Psychology

Background:

• The endocannabinoid system plays a crucial role in regulating various physiological and behavioral processes.
• Ultrasonic vocalizations (USVs) in infant rodents serve as important social communication signals.
• Understanding the neurochemical modulation of USVs is vital for studying early development and communication.

Purpose of the Study:

• To investigate the effects of cannabinoid receptor agonist CP 55,940 and antagonist SR 141716A on USVs, body temperature, and activity in young rat pups.
• To determine if the effects of CP 55,940 on USVs are mediated by hypothermia or other receptor systems.
• To explore the potential involvement of the endogenous cannabinoid system in regulating pup USVs.

Main Methods:

• Administration of CP 55,940 (a cannabinoid agonist) and SR 141716A (a cannabinoid antagonist) to 11-13-day-old rat pups.
• Measurement of ultrasonic vocalizations, body temperature, and general activity levels following drug administration.
• Testing the effects of other receptor antagonists (flumazenil, SCH 23390, naloxone) on CP 55,940-induced changes.

Main Results:

• CP 55,940 dose-dependently decreased USVs and, at higher doses, reduced body temperature and activity.
• SR 141716A reversed the effects of CP 55,940 on USVs and body temperature, but other antagonists did not.
• SR 141716A alone increased USVs without affecting temperature or activity, suggesting a role for endogenous cannabinoids.

Conclusions:

• Cannabinoids modulate ultrasonic vocalization production in rat pups independently of hypothermic effects.
• The endogenous cannabinoid system, potentially via anandamide, appears to regulate USV production in developing rats.
• SR 141716A's ability to increase USVs provides novel insights into the behavioral effects of cannabinoid receptor blockade.